AN2 Therapeutics, Inc. (ANTX) Misses Q1 EPS by 6c
Tweet
Share
E-mailGet Alerts ANTX Hot Sheet
Join SI Premium – FREE
AN2 Therapeutics, Inc. (NASDAQ: ANTX) reported Q1 EPS of ($0.29), $0.06 worse than the analyst estimate of ($0.23).
For earnings history and earnings-related data on AN2 Therapeutics, Inc. (ANTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
- Active options: TSLA NVDA SPCX MU AAPL AMD INTC AMZN
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
